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Although capsaicin provocation has been used to evaluate treatment against cough, which is one of the most
common respiratory symptoms, there are still methodological considerations that are not fully known. Capsaicin
stimulates the unmyelinated slow C-fibres of the sensory nervous system, which leads to coughing. Smoking often
leads to respiratory symptoms with cough and phlegm. The aim of this study was to examine the effect of smoking
on capsaicin provocation. Subjectively healthy smokers and non-smokers were challenged with capsaicin in
increasing doses. The coughs were counted and irritation of the lower airways was graded on a symptom score.
Smokers reacted to provocation with significantly fewer coughs, but there was no difference regarding other
symptoms. These results are in agreement with the hypothesis that nicotine inhibits or blocks C-fibres of the sensory
nervous system of the lower respiratory tract.
Clinically, this may serve to explain increasing airway symptoms that are often seen after cessation of smoking.
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Capsaicin, an ingredient in red pepper, is known to
stimulate the unmyelinated slow C-fibres of the sensory
nervous system. In fact, the C-fibres are characterized by
their sensitivity to the neurotoxin capsaicin (1). In small
doses, capsaicin releases neuropeptides from the C-fibre
endings, while in high doses it effectively eliminates the
neuropeptides. These neuropeptides, including the tachyki-
nins substance P, neurokinin A and calcitonin gene-related
peptide (CGRP), are found in vesicles in the C-fibres of the
respiratory epithelium. Activation leads to various effects,
such as cough, bronchoconstriction and mucous secretion
(1). The tachykinins have potent inflammatory effects and
are important agents in what is called ‘neurogenic
inflammation’.
Inhalation of capsaicin has previously been used to
induce cough in provocation models and for testing anti-
tussive drugs (2–7). Capsaicin has been used previously in
cough provocation to differentiate between patients with
sensory hyperreactivity and healthy subjects or patients
with asthma (8,9). Patients with sensory hyperreactivity but
no asthma or allergy complained of symptoms from the
upper and/or lower respiratory tract after having been
exposed to chemical agents such as strong scents. It was
found that these patients reacted with increased coughingReceived 11 August 2000 and accepted 4 September 2000.
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ducible in controlled experiments (8).
In the authors’ studies of sensory hyperreactivity, it was
found that smokers reacted with less coughing than non-
smokers to provocation with capsaicin. This was astonish-
ing as smoking often leads to chronic bronchitis, with
coughing as a major symptom. The authors often meet ex-
smokers in their practice, who after cessation, show
increased symptoms of the respiratory tract. The hypothesis
is that nicotine inhibits the receptors of the C-fibres of the
sensory nerves in the respiratory epithelium or induces a
depletion of neuropeptides, and thus inhibits coughing. To
test this hypothesis, the effect of cough provocation with
capsaicin in a group of smokers and a group of non-
smokers was compared, all subjects being without respira-
tory symptoms.
Materials and methods
Fifteen regular smokers, 10 women and five men (aged 15–
60 years, mean age 43 years), were recruited for the study.
They were compared with 39 non-smoking volunteers, 32
women and seven men (aged 24–57 years, mean age 43
years). The smokers as well as the controls were subjectively
healthy and on no regular treatment with any drug. None
of the subjects had a history of obstructive pulmonary
disease. Smokers were included if they had smoked five or
more cigarettes per day for at least 1 year, with an average
of 12?5 (+4?6 SD) cigarettes day71. A questionnaire was
used to identify smoking habits.# 2001 HARCOURT PUBLISHERS LTD
20 E. MILLQVIST AND M. BENDEProvocation with capsaicin started with inhalation of
1ml capsaicin (0?4mM) for 6min, followed by a 4min rest,
in accordance with a previous study (8). The number of
coughs was counted for 10min from the start of the
provocation, and recorded on a tape recorder. Thereafter,
the provocations continued in the same way with increasing
concentrations of capsaicin, viz. 2 mM and 10 mM in a 1ml
solution. If a subject coughed 70 times with any of the
doses, the test was discontinued. The effect parameters were
number of coughs and degree of irritation from the lower
airways after each dose of capsaicin. The degree of
irritation was graded from 0 to 3 (‘no symptoms’ to ‘very
irritated’).
Student’s t-test was used to compare smokers’ and non-
smokers’ reactions to each concentration. Analysis of
variance (ANOVA) was used for a complete comparison
of both the cough and the symptoms. The local ethics
committee approved the study and all subjects gave
informed consent.
Results
Capsaicin induced dose-dependent coughs in all subjects,
with a statistically significant difference between smokers
and non-smokers for the two highest concentrations
(P50?01) (Fig. 1). The mean number of coughs for
capsaicin 0?4mM in smokers was 0?2 (confidence interval
0; 0?4) and in non-smokers, 2?0 (0?8; 12?4). Corresponding
values for capsaicin 2 mM were 2?1 (0?5; 3?7) and 9?5 (6?6;
12?4), and for capsaicin 10 mM, 14?3 (8?1; 20?6) and 26?0
(21?2; 30?8). Examination by ANOVA showed a statisti-
cally significant difference between smokers and non-
smokers (P50?005).
In general, the irritation in the lower airways induced by
the capsaicin provocations was minor. With increasing
doses of capsaicin, symptoms increased (Fig. 2). Regarding
symptoms, there was no statistically significant differenceFIG. 1. Mean number of coughs (+SEM) in smokers and
non-smokers elicited by provocation with three doses of
capsaicin.&, Non-smokers;*, smokers. ****P50?0001;
***P50?001; and **P50?01. Examination by ANOVA
showed a statistically significant difference (P50?005)
between smokers (n¼ 15) and non-smokers (n¼ 39).between smokers and non-smokers for any concentration,
nor was there any overall difference between the groups. In
the smokers, there was no relationship between number of
cigarettes smoked daily and coughs after capsaicin provo-
cation.
Discussion
The present study confirms the authors’ observation that
smokers react to capsaicin provocation with less coughing
than non-smokers. The difference in coughing between the
groups was obvious, but there was no difference regarding
symptoms. Respiratory reflexes evoked by nicotine are
similar to those produced by capsaicin but it is unclear
whether the same type of sensory nerves mediates these
reflexes (4). It is possible that nicotine in high doses
eliminates the neuropeptides from the C-fibre endings in a
similar way that capsaicin does (1). Such a theory may
provide an explanation for these results and may also
explain the increasing symptoms from the upper and lower
airways so often seen in patients who have ceased to smoke.
Cough provocation with capsaicin has often been
performed on non-smoking subjects (4,7,8). After cough
provocation with citric acid, a comparison has been made
previously between moderate smokers (10–20 cigarettes
day71), occasional smokers (1–5 cigarettes week71) and
non-smokers (10). The study showed that moderate
smokers tend to cough more than non-smokers; the
occasional smokers in the study did not cough at all (10).
In another study, cough threshold for citric acid and
capsaicin was evaluated in patients with chronic obstructive
pulmonary disease (11). These patients were all smokers
with a reduced lung function and with limited reversibility
on terbutaline. Healthy, non-smoking subjects were used as
controls. The results showed that patients with chronic
obstructive pulmonary disease had a significantly lower
cough threshold to citric acid. However, there was noFIG. 2. Mean symptom score of irritation of the lower
airways (+SEM) in smokers and non-smokers elicited by
provocation with three doses of capsaicin. &, Non-
smokers; *, smokers. ***P50?001; **P50?01. Analysis
by ANOVA showed no statistically significant difference
between smokers (n¼ 15) and non-smokers (n¼ 39).
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Wong and Morice postulated that citric acid and capsaicin
stimulate cough through different mechanisms. A lower
threshold to citric acid implied an increased sensitivity.
These findings are in contrast to the present study in which
a decreased sensitivity in smokers was found. Differences in
materials and methods used may be one explanation for
this discrepancy. The smokers in the present study were not
patients and had no history of pulmonary disease.
Furthermore, the method of provocation differed. Wong
and Morice exposed their subjects to provocation with
citric acid immediately followed by capsaicin (11), using
increasing doses until patients achieved two coughs. The
authors then constructed a log dose–response curve for
each test and calculated the cough threshold by linear
regression. All subjects were provoked with the same doses
and the number of coughs for each dose were counted. Both
methods of provocation have been described in the
literature; the authors showed a good reproducibility by
provoking all subjects with constant doses (8).
Cough is one of the most common respiratory symptoms
and capsaicin provocation is an established method of
studying cough. Therefore, it is important to know more
about the effect of smoking on capsaicin provocation. It has
previously been found that men are more sensitive to
capsaicin than women, and that upper respiratory tract
infections increase the sensitivity (5,6). In the present study,
lung function was not measured but none of the subjects
had a history of any airway symptom or had ever been on
any therapy for asthma or bronchitis. Furthermore, in
previous studies, provocation with capsaicin did not alter
lung function (8,9).
The authors conclude that smokers are less sensitive to
capsaicin than non-smokers, which supports the hypothesis
that nicotine either inhibits the receptors of the C-fibres of
the sensory nerves in the respiratory epithelium, or induces
a depletion of neuropeptides. Clinically, this may serve to
explain increasing airway symptoms that are often seen
after cessation of smoking.
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